FONT-SIZE Plus   Neg

Deluxe Q1 Profit Rises

Deluxe Corp. (DLX) Thursday reported an increase in profit for the first quarter, due mainly to higher revenues.

The Shoreview, Minnesota-based company reported first-quarter net profit of $44.1 million or $0.86 per share, compared to $32.6 million or $0.63 per share last year.

Adjusted earnings for the quarter rose to $0. 88 per share from $0.75 per share in the prior-year quarter. On average, three analysts polled by Thomson Reuters expected the company to earn $0.79 per share for the quarter. Analysts' estimates typically exclude special items.

Total revenues for the quarter grew 8.1 percent to $378.0 million from $349.8 million in the prior-year quarter.

Looking ahead, the company expects second-quarter earnings in the range of $0.74 to $0.79 per share and adjusted earnings of $0.76 to $0.81 per share. Revenues for the second quarter are anticipated in the range of $353 million to $362 million. Analysts currently expect the company to earn $0.78 per share for the quarter.

The company increased its earnings guidance for the full-year 2012 to a range of $3.12 to $3.32 per share from previous estimate of $3.10 to $3.30 per share. The company also lifted its adjusted earnings guidance to a range of $3.20 to $3.40 per share, compared to prior estimate of $3.10 to $3.30 per share. Analysts currently expect the company to earn $3.21 per share for the quarter.

Deluxe now expects revenues for 2012 in the range of $1.45 billion to $1.48 billion compared to previous estimate of $1.42 billion to $1.46 billion.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Electric car maker Tesla Motors Inc. (TSLA), Wednesday reported a profit for the third quarter beating Wall Street estimates by a large margin, driven primarily by record production and deliveries. Shares of the company gained over 5 percent in extended hours after the company reaffirmed its delivery... Auvi-Q, the rival for EpiPen, will be coming back in 2017, pharmaceutical company Kaleo announced on Wednesday. Auvi-Q is a epinephrine injection used to treat life-threatening allergic reactions, including anaphylaxis, in people who are at risk for or have a history of serious allergic reactions. Auvi-Q... Uber's self-driving technology start-up Otto has partnered with Anheuser-Busch InBev to complete the world's first shipment by a self-driving truck. Otto said in a blog post that the company and Anheuser-Busch delivered 51,744 cans of Budweiser beer from Fort Collins, through downtown Denver, to Colorado Springs.
comments powered by Disqus
Follow RTT